Apr 8, 2025, 08:15 by

Indivumed is proud to announce major milestones achieved, cementing its position as a leading oncology R&D company.

Apr 8, 2025, 08:15 by

New name reflects company’s growth and vision to help bring certainty and transparency to global clinical trials

Apr 7, 2025, 09:08 by

Cloud CTMS software to improve research site efficiency and integrate seamlessly with sponsors.

Apr 7, 2025, 09:08 by

WCG has announced the release of Research Resilience Solutions, a site optimization initiative and industry-wide thought leadership series aimed at supporting institutions facing significant funding constraints.

Apr 7, 2025, 09:08 by

ONTOFORCE has announced a collaboration with The Michael J. Fox Foundation for Parkinson’s Research (MJFF).

Apr 7, 2025, 09:08 by

Apr 3, 2025, 01:00 by User Not Found

Clinical Research News | Pragmatic trials, by name, have been around for well over a decade now and, while well intentioned, they remain poorly understood and currently offer a limited value proposition to study sponsors and contract research organizations.

Apr 2, 2025, 01:00 by User Not Found

Clinical Research News | Body Mass Index (BMI) is a long-used method to measure body fat with the formula kg/m2 (or lbs/in2 x 703 for imperial measurements). While it is a noninvasive and inexpensive way to measure body fat, there are arguments that BMI is inaccurate because it does not include other factors such as fat distribution, muscle mass, and metabolic health.

Apr 1, 2025, 11:13 by

CluePoints, provider of leading statistical and AI-driven software solutions, has today announced Usama Dar as its new Chief Product and Technology Officer.

Apr 1, 2025, 11:13 by

Mar 28, 2025, 08:32 by

Genomenon and Genomize today announced a new partnership that brings together the best of genomic intelligence and next-generation sequencing technology to transform how genomic data is interpreted. Through this integration, Genomenon’s Mastermind® Genomic Intelligence Platform and Cancer Knowledgebase (CKB) are now seamlessly embedded within Genomize’s SEQ Platform, enabling a unified and deeply enriched analysis environment. This partnership marks a major step forward in streamlining genomic analysis and advancing precision medicine—especially across Europe, the Middle East, and Asia, where Genomize is actively leading innovation.

Mar 28, 2025, 08:32 by

WCG announced today the launch of WCG ClinSphere™ Total Feasibility’s Software-as-a-Service (SaaS) technology solution, designed to address the most important clinical trial study start-up decisions for sponsors and contract research organizations (CROs).

Mar 28, 2025, 01:00 by User Not Found

Clinical Research News | Marieme Ba, CEO of Pharmalys, discusses the underrepresentation of African countries in clinical research. Study protocols she worked on referenced continents, except Africa. Other African countries were occasionally included in clinical trials for infectious diseases, but for the most part, the continent was overlooked. This begs the question: why is Africa not represented?

Mar 27, 2025, 08:13 by

Mar 27, 2025, 08:13 by

Andaman7, the platform transforming healthcare communications and bridging the gap between patients and researchers, is seeking investment to reach the next milestones in its ground-breaking journey.

Mar 27, 2025, 01:00 by User Not Found

Clinical Research News | Digital Health Measurement Collaborative Community by the Digital Medicine Society released a suite of resources designed to effectively demonstrate the value of using digital endpoints in clinical trials; The Pistoia Alliance launched the next phase of its project to measure and reduce the carbon footprint of clinical trials; and more.

Mar 26, 2025, 01:00 by User Not Found

Clinical Research News | Eikon will advance its programs aimed to treat advanced melanoma, as well as breast, ovarian, prostate, pancreatic, and brain cancers; Callio launches with innovative multi-payload programs designed to maximize therapeutic benefit for cancer patients; and more.

Mar 25, 2025, 08:03 by

Mar 24, 2025, 08:22 by

Anthos Therapeutics, Inc., a business that produces abelacimab (full human monoclonal antibody), a late-stage medication being developed to prevent stroke and systemic embolism in patients with atrial fibrillation, has agreed to be acquired by Novartis. Upon concluding the deal, Novartis will pay $925 million upfront, subject to certain usual adjustments. If certain sales and regulatory milestones are met, Novartis may also pay an additional $2.15 billion.

Mar 24, 2025, 08:22 by

Upperton Pharma Solutions, a leading UK-based contract development and manufacturing organisation (CDMO), is proud to announce its selection as Champion Winner in the Small Molecule Dosage Form – International category at the 2025 CDMO Leadership Awards.